Cover Image

Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial

Abstract Background Currently, there are no medications approved for the treatment of juvenile fibromyalgia (JFM). We evaluated the safety and efficacy of duloxetine 30/60 mg once daily (QD) versus placebo in adolescents with JFM. Methods In this Phase 3b, multisite (US, Argentina, Puerto Rico, and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Himanshu P. Upadhyaya (Author), Lesley M. Arnold (Author), Karla Alaka (Author), Meihua Qiao (Author), David Williams (Author), Renata Mehta (Author)
Format:	Book
Published:	BMC, 2019-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial
by: Mansoor Shakiba, et al.
Published: (2018)

Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia
by: Ellis JJ, et al.
Published: (2014)

Comparison of the Efficacy of Duloxetine Versus Pregabalin for Pain Relief of Neuropathy in Diabetics
by: Hamid Raza Gulzar, et al.
Published: (2024)

Analgesic Effect of Duloxetine Compared to Nortryptiline in Patients with painful Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
by: Mohammadali Bayani, et al.
Published: (2021)

Duloxetine in the management of chronic musculoskeletal pain
by: Smith EJ, et al.
Published: (2012)

Acute generalized exanthematous pustulosis induced by duloxetine
by: Numa Deydier, et al.
Published: (2023)

Juvenile primary fibromyalgia syndrome: A Review- Treatment and Prognosis
by: Maya Levy Coles, et al.
Published: (2021)

Duloxetine in addition to self-management for painful temporomandibular disorders: a post hoc responder analysis of a randomized, placebo-controlled clinical trial
by: Dyna Mara Araújo Oliveira FERREIRA, et al.
Published: (2024)

Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary
by: Susan G Ball, et al.
Published: (2013)

Effectiveness of Duloxetine versus Other Therapeutic Modalities in Patients with Diabetic Neuropathic Pain: A Systematic Review and Meta-Analysis
by: Juan José Valenzuela-Fuenzalida, et al.
Published: (2024)

Continuation treatment of major depressive disorder: is there a case for duloxetine?
by: Trevor R Norman, et al.
Published: (2010)

Patient-proxy agreement on health-related quality of life in juvenile fibromyalgia syndrome
by: Sabrina Gmuca, et al.
Published: (2019)

Characterizing Neurocognitive Impairment in Juvenile Fibromyalgia Syndrome: Subjective and Objective Measures of Dyscognition
by: Sabrina Gmuca, et al.
Published: (2022)

Juvenile primary Fibromyalgia Syndrome: epidemiology, etiology, pathogenesis, clinical manifestations and diagnosis
by: Maya Levy Coles, et al.
Published: (2021)

The role of benign joint hypermobility in the pain experience in Juvenile Fibromyalgia: an observational study
by: Ting Tracy V, et al.
Published: (2012)

Role of Duloxetine as Adjuvant in Chemotherapy Induced Peripheral Neuropathic Pain-An Update
by: Kalpajit Dutta, et al.
Published: (2016)

Formulation and optimization of duloxetine hydrochloride buccal films: in vitro and in vivo evaluation
by: Amr Mostafa El Sharawy, et al.
Published: (2017)

Duloxetine treatment adherence across mental health and chronic pain conditions
by: Able SL, et al.
Published: (2014)

Pain, functional disability, and their Association in Juvenile Fibromyalgia Compared to other pediatric rheumatic diseases
by: Mark Connelly, et al.
Published: (2019)

Suicidal risk and resilience in juvenile fibromyalgia syndrome: a cross-sectional cohort study
by: Sabrina Gmuca, et al.
Published: (2021)

Preparation and evaluation of duloxetine hydrochloride enteric-coated pellets with different enteric polymers
by: Chen Kuang, et al.
Published: (2017)

Optimization of initial dosage of quetiapine in schizophrenic patients: effects of fluvoxamine or duloxetine coadministration
by: Xiao Chen, et al.
Published: (2024)

A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain
by: King JB, et al.
Published: (2015)

VOSviewer-Based Bibliometric Network Analysis for Evaluating Research on Juvenile Primary Fibromyalgia Syndrome (JPFS)
by: Alessandro Vittori, et al.
Published: (2022)

Correction to: Pain, functional disability, and their Association in Juvenile Fibromyalgia Compared to other pediatric rheumatic diseases
by: Mark Connelly, et al.
Published: (2020)

Duloxetine Exposure During Pregnancy and the Risk of Offspring Being Born Small for Gestational Age or Prematurely: A Nationwide Danish and Swedish Safety Study
by: Mikkel Zöllner Ankarfeldt, et al.
Published: (2022)

Analgesic Effects of Duloxetine on Formalin-Induced Hyperalgesia and Its Underlying Mechanisms in the CeA
by: Lie Zhang, et al.
Published: (2018)

A qualitative study of risk and resilience in young adult women with a history of juvenile-onset fibromyalgia
by: Morgan Daffin, et al.
Published: (2021)

Pharmacotherapy for Fibromyalgia
by: Howard eSmith, et al.
Published: (2011)

Pediatric fibromyalgia
by: J. Ablin, et al.
Published: (2012)

Fibromyalgia and arthritides
by: A. Alciati, et al.
Published: (2012)

Alleviation of notalgia paresthetica with duloxetine after several lines offailed treatment: A case report
by: Amnon A. Berger, et al.
Published: (2020)

Formulation, optimization, in-vivo biodistribution studies and histopathological safety assessment of duloxetine HCl-loaded ultra-elastic nanovesicles for antidepressant effect after intranasal and transdermal delivery
by: Radwa M.A. Abd-Elal, et al.
Published: (2023)

Efficacy and Safety of Rifaximin Versus Placebo or Other Active Drugs in Critical ill Patients With Hepatic Encephalopathy
by: Xianghui Han, et al.
Published: (2021)

The effects of joint hypermobility on pain and functional biomechanics in adolescents with juvenile fibromyalgia: secondary baseline analysis from a pilot randomized controlled trial
by: William R. Black, et al.
Published: (2023)

Psychiatric problems in fibromyalgia: clinical and neurobiological links between mood disorders and fibromyalgia
by: F. Atzeni, et al.
Published: (2012)

New Insights into Fibromyalgia
Published: (2012)

Etiology and pathophysiology of fibromyalgia
by: Ana Placida Marino Chamani Almanza, et al.
Published: (2023)

Fibromyalgia: recommendations and possibilities
by: Amélia Pasqual Marques
Published: (2014)

Symptoms accompanying fibromyalgia
by: M. Maresca, et al.
Published: (2011)